The Journal of Immunology, Vol 140, Issue 9 2903-2911, Copyright © 1988 by American Association of Immunologists

ARTICLES

Mechanism of protection from graft-vs-host disease in murine mixed allogeneic chimeras. I. Development of a null cell population suppressive of cell-mediated lympholysis responses and derived from the syngeneic bone marrow component

M Sykes, A Eisenthal and DH Sachs
Immunology Branch, National Cancer Institute, Bethesda, MD 20892.

Splenocyte populations from whole body-irradiated recipients of mixed T cell-depleted (TCD) syngeneic and allogeneic (complete H-2 disparity) bone marrow, or of TCD syngeneic marrow alone, contain cells with the ability to suppress the generation of cell-mediated lympholysis responses in vitro. This activity, which is present by 8 days after bone marrow transplantation and persists for several weeks, has been analyzed for possible veto-like or other specificity. Although reproducible patterns of suppression were observed, depending both on host strain and on the genetic combination of the response examined, the overall suppression in vitro most closely resembles that which has been ascribed to "natural suppressor" cells in other systems. The suppression appears to be mediated by a non-T cell, non-B cell, nonadherent, asialo GM1-negative population. Cold target inhibition and CTL activity of chimeric cells have been ruled out as factors contributing to the observed suppression. Significantly, in mixed chimeras, suppression was found to be mediated exclusively by cells which were syngeneic to the recipient in both recipient strains tested. The rapid development of this suppressive activity may explain the resistance to graft-vs-host disease conferred on whole body-irradiated mice by the addition of TCD syngeneic marrow to an allogeneic graft-vs- host disease-producing inoculum.

This article has been cited by other articles:

				F. Locatelli Reduced-Intensity Regimens in Allogeneic Hematopoietic Stem Cell Transplantation for Hemoglobinopathies Hematology, January 1, 2006; 2006(1): 398 - 401. [Abstract] [Full Text] [PDF]

				A. D. Billiau, S. Fevery, O. Rutgeerts, W. Landuyt, and M. Waer Transient expansion of Mac1+Ly6-G+Ly6-C+ early myeloid cells with suppressor activity in spleens of murine radiation marrow chimeras: possible implications for the graft-versus-host and graft-versus-leukemia reactivity of donor lymphocyte infusions Blood, July 15, 2003; 102(2): 740 - 748. [Abstract] [Full Text] [PDF]

				F. Locatelli, V. Rocha, W. Reed, F. Bernaudin, M. Ertem, S. Grafakos, B. Brichard, X. Li, A. Nagler, G. Giorgiani, et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease Blood, March 15, 2003; 101(6): 2137 - 2143. [Abstract] [Full Text] [PDF]

				M. Zecca, A. Prete, R. Rondelli, E. Lanino, A. Balduzzi, C. Messina, F. Fagioli, F. Porta, C. Favre, A. Pession, et al. Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome Blood, July 30, 2002; 100(4): 1192 - 1200. [Abstract] [Full Text] [PDF]

				M. E. Horwitz, A. J. Barrett, M. R. Brown, C. S. Carter, R. Childs, J. I. Gallin, S. M. Holland, G. F. Linton, J. A. Miller, S. F. Leitman, et al. Treatment of Chronic Granulomatous Disease with Nonmyeloablative Conditioning and a T-Cell-Depleted Hematopoietic Allograft N. Engl. J. Med., March 22, 2001; 344(12): 881 - 888. [Abstract] [Full Text] [PDF]

				B. R. Blazar, C. J. Lees, P. J. Martin, R. J. Noelle, B. Kwon, W. Murphy, and P. A. Taylor Host T Cells Resist Graft-Versus-Host Disease Mediated by Donor Leukocyte Infusions J. Immunol., November 1, 2000; 165(9): 4901 - 4909. [Abstract] [Full Text] [PDF]

				F. Locatelli, B. Bruno, M. Zecca, M. T. Van-Lint, S. McCann, W. Arcese, S. Dallorso, P. Di Bartolomeo, F. Fagioli, A. Locasciulli, et al. Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial Blood, September 1, 2000; 96(5): 1690 - 1697. [Abstract] [Full Text] [PDF]

				H. Hayashi, J. Toki, L. Zhexiong, K. Sugiura, K. Inoue, and S. Ikehara Long-Term (>1 year) Analyses of Chimerism and Tolerance in Mixed Allogeneic Chimeric Mice Using Normal Mouse Combinations Stem Cells, July 1, 2000; 18(4): 273 - 280. [Abstract] [Full Text]

				G. R. Hill, J. M. Crawford, K. R. Cooke, Y. S. Brinson, L. Pan, and J. L.M. Ferrara Total Body Irradiation and Acute Graft-Versus-Host Disease: The Role of Gastrointestinal Damage and Inflammatory Cytokines Blood, October 15, 1997; 90(8): 3204 - 3213. [Abstract] [Full Text] [PDF]